Impaired synaptic vesicle recycling contributes to presynaptic dysfunction in lipoprotein lipase-deficient mice

Neuroscience. 2014 Nov 7:280:275-81. doi: 10.1016/j.neuroscience.2014.07.080. Epub 2014 Sep 3.

Abstract

Lipoprotein lipase (LPL) is expressed at high levels in hippocampal neurons, although its function is unclear. We previously reported that LPL-deficient mice have learning and memory impairment and fewer synaptic vesicles in hippocampal neurons, but properties of synaptic activity in LPL-deficient neurons remain unexplored. In this study, we found reduced frequency of miniature excitatory postsynaptic currents (mEPSCs) and readily releasable pool (RRP) size in LPL-deficient neurons, which led to presynaptic dysfunction and plasticity impairment without altering postsynaptic activity. We demonstrated that synaptic vesicle recycling, which is known to play an important role in maintaining the RRP size in active synapses, is impaired in LPL-deficient neurons. Moreover, lipid assay revealed deficient docosahexaenoic acid (DHA) and arachidonic acid (AA) in the hippocampus of LPL-deficient mice; exogenous DHA or AA supplement partially restored synaptic vesicle recycling capability. These results suggest that impaired synaptic vesicle recycling results from deficient DHA and AA and contributes to the presynaptic dysfunction and plasticity impairment in LPL-deficient neurons.

Keywords: lipoprotein lipase; presynaptic dysfunction; readily releasable pool (RRP); synaptic plasticity; synaptic vesicle recycling.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Arachidonic Acid / administration & dosage
  • Arachidonic Acid / metabolism
  • Docosahexaenoic Acids / administration & dosage
  • Docosahexaenoic Acids / metabolism
  • Excitatory Postsynaptic Potentials / drug effects
  • Excitatory Postsynaptic Potentials / physiology
  • Gas Chromatography-Mass Spectrometry
  • Hippocampus / drug effects
  • Hippocampus / physiopathology*
  • Hyperlipoproteinemia Type I / drug therapy
  • Hyperlipoproteinemia Type I / physiopathology
  • Lipoprotein Lipase / deficiency*
  • Lipoprotein Lipase / genetics
  • Male
  • Mice, Inbred C57BL
  • Miniature Postsynaptic Potentials / drug effects
  • Miniature Postsynaptic Potentials / physiology
  • Patch-Clamp Techniques
  • Presynaptic Terminals / drug effects
  • Presynaptic Terminals / enzymology*
  • Pyramidal Cells / drug effects
  • Pyramidal Cells / physiopathology
  • Synaptic Vesicles / drug effects
  • Synaptic Vesicles / enzymology*
  • Tissue Culture Techniques

Substances

  • Docosahexaenoic Acids
  • Arachidonic Acid
  • Lipoprotein Lipase